filings.toolsItem 16. Form 10-K Summary.
2K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary.
A Form 10-K summary is provided at the beginning of this document, with hyperlinked cross-references. This allows users to easily locate the corresponding items in Form 10-K, where the disclosure is fully presented. The summary does not include certain Part III information that is incorporated by reference from a future proxy statement filing.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| 3M COMPANY | |
| By | /s/ Nicholas C. Gangestad |
| Nicholas C. Gangestad, | |
| Senior Vice President and Chief Financial Officer | |
| (Principal Financial Officer) | |
| February 7, 2019 |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated on February 7, 2019.
| Signature | Title | |
| Inge G. Thulin | Executive Chairman of the Board | |
| Michael F. Roman | Chief Executive Officer, Director (Principal Executive Officer) | |
| Ippocratis Vrohidis | Vice President, Corporate Controller and Chief Accounting Officer (Principal Accounting Officer) | |
| Sondra L. Barbour | Director | |
| Thomas K. Brown | Director | |
| David B. Dillon | Director | |
| Michael L. Eskew | Director | |
| Herbert L. Henkel | Director | |
| Amy E. Hood Muhtar Kent | Director Director | |
| Edward M. Liddy | Director | |
| Dambisa F. Moyo | Director | |
| Gregory R. Page | Director | |
| Patricia A. Woertz | Director |
Nicholas C. Gangestad, by signing his name hereto, does hereby sign this document pursuant to powers of attorney duly executed by the other persons named, filed with the Securities and Exchange Commission on behalf of such other persons, all in the capacities and on the date stated, such persons constituting a majority of the directors of the Company.
| By | /s/ Nicholas C. Gangestad |
| Nicholas C. Gangestad, Attorney-in-Fact |
Previous: Item 15. Exhibits, Financial Statement Schedules.